Get the Stockscreener App
4.65
0.00%
0.00
After Hours:
4.65
Endra Life Sciences Inc stock is traded at $4.65, with a volume of 11,310.
It is up +0.00% in the last 24 hours and up +12.05% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$4.65
Open:
$4.39
24h Volume:
11,310
Relative Volume:
0.11
Market Cap:
$5.42M
Revenue:
-
Net Income/Loss:
$-8.01M
P/E Ratio:
-0.3472
EPS:
-13.3923
Net Cash Flow:
$-5.10M
1W Performance:
+24.00%
1M Performance:
+12.05%
6M Performance:
-17.23%
1Y Performance:
+18.62%
1-Day Range:
$4.39
$4.75
1-Week Range:
$3.75
$4.9799
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.65 | 5.42M | 0 | -8.01M | -5.10M | -13.39 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Endra Life Sciences Inc Stock (NDRA) Latest News
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - tradingview.com
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - gurufocus.com
ENDRA Life Sciences (NASDAQ: NDRA) flags going-concern risk and pivots to digital asset treasury - Stock Titan
ENDRA Life Sciences Q4 net loss narrows - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) cuts 2025 operating costs sharply - Stock Titan
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - businesswire.com
Day Trade: Whats the MACD signal for ENDRA Life Sciences Inc2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
Movement Recap: Does ENDRA Life Sciences Inc outperform in volatile marketsWeekly Market Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com
NDRA Ignites: 20% Surge Signals Strategic Overhaul as Capital Hunt for Micro-Cap Alphas - Bitget
12 Health Care Stocks Moving In Thursday's Intraday Session - benzinga.com
ENDRA Life Sciences Explores Strategic Alternatives Amid Restructuring - theglobeandmail.com
ENDRA Life Sciences explores strategic alternatives By Investing.com - in.investing.com
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside - FinancialContent
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value - BioSpace
Strategic options review launched by ENDRA Life Sciences (Nasdaq: NDRA) - Stock Titan
ENDRA Life Sciences explores strategic alternatives - Investing.com
ENDRA (NDRA) Explores Strategic Options to Enhance Shareholder V - gurufocus.com
ENDRA Life Sciences Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value - marketscreener.com
ENDRA Life Sciences Inc announced that its Board of Directors has initiated a strategic review process aimed at a comprehensive assessment of the company’s future development pathways. - Bitget
ENDRA Life Sciences (NDRA) Expected to Announce Quarterly Earnings on Monday - Defense World
If You Invested $1,000 in Endra Life Sciences Inc (NDRA) - Stock Titan
Tech Rally: Is ENDRA Life Sciences Inc being accumulated by smart money2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Stocks Under $10: IBRX, VTIX, NDRA, SMX2026 Watch Now! - openPR.com
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - The Norfolk Daily News
IBRX, VTIX, NDRA, SMX – 2026 Watch Now! - FinancialContent
ENDRA Life Sciences (NASDAQ: NDRA) - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play In The $100B+MASH+GLP-1 Healthcare Boom - Mena FN
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
User - The Chronicle-Journal
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now! - Barchart.com
FinancialContentFavorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - FinancialContent
Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA - FinancialContent
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA) - Barchart
Favorable Results on Liver Device for Long-Term Monitoring - openPR.com
Will ENDRA Life Sciences Inc. stock outperform growth indexesWeekly Trend Summary & Reliable Entry Point Alerts - Naître et grandir
[Form 4] ENDRA Life Sciences Inc. Insider Trading Activity - Stock Titan
ENDRA Life Sciences (NDRA) CFO awarded 13,461 restricted stock units - Stock Titan
NDRA's TAEUS system Reaches MRI-Comparable Accuracy in Liver Imaging - Bitget
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision - TradingView
NDRA Should I Buy - Intellectia AI
NDRA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Le - PharmiWeb.com
Endra Life Sciences (NDRA) Announces Positive Trial Results for Liver Device - GuruFocus
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care - Yahoo Finance
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now! - openPR.com
Sell Signal: What are the future prospects of ENDRA Life Sciences Inc2025 Market Trends & Verified Momentum Stock Alerts - baoquankhu1.vn
Does ENDRA Life Sciences Inc. outperform in volatile marketsJuly 2025 Reactions & Weekly Top Stock Performers List - mfd.ru
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):